Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesMolecular ImagingSNMMI: Dual-targeting radioligand therapy safe for several cancersA new "dual-targeting" radioligand therapy has been shown to be safe and effective in humans.Molecular ImagingVideo from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelinesMolecular ImagingSNMMI: Dual PET/MRI technique could help manage primary aldosteronismMolecular ImagingSNMMI: Retreatment with Lu-177 PSMA-617 shows promise in mCRPC patientsSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!
